Lyra Therapeutics (LYRA) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Lyra Therapeutics (LYRA) over the last 5 years, with Q3 2025 value amounting to 0.02.
- Lyra Therapeutics' Asset Utilization Ratio fell 21430.96% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 21430.96%. This contributed to the annual value of 0.01 for FY2023, which is 2539.93% down from last year.
- According to the latest figures from Q3 2025, Lyra Therapeutics' Asset Utilization Ratio is 0.02, which was down 21430.96% from 0.01 recorded in Q2 2025.
- In the past 5 years, Lyra Therapeutics' Asset Utilization Ratio registered a high of 0.02 during Q3 2024, and its lowest value of 0.02 during Q3 2025.
- Over the past 5 years, Lyra Therapeutics' median Asset Utilization Ratio value was 0.01 (recorded in 2023), while the average stood at 0.01.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 15561.84% in 2022, then plummeted by 21430.96% in 2025.
- Quarter analysis of 5 years shows Lyra Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then soared by 155.62% to 0.01 in 2022, then dropped by 0.35% to 0.01 in 2023, then surged by 43.35% to 0.02 in 2024, then tumbled by 214.31% to 0.02 in 2025.
- Its Asset Utilization Ratio stands at 0.02 for Q3 2025, versus 0.01 for Q2 2025 and 0.01 for Q1 2025.